Paul A. Mahon, EVP & General Counsel: United Therapeutics UTHR Sell · Filed 25/08/22

Trade details

Type: Insider sale
Amount: $1,310,126.62
Shares · price: 4,234 sh · $309.43 a share
Held after: 38,876 sh
Stock: United Therapeutics UTHR
Person: Paul A. MahonEVP & General Counsel
Trade date: 25/08/21
Filed: 25/08/22
Days to filing: 1 days

Sold 9.8% of holdings

Share of holding sold: 9.8%

United Therapeutics trades, last 26 weeks

What else happened in United Therapeutics around then

Filed or reported within 30 days of the trade day · 25/07/22~25/09/20

Paul A. Mahon's recent trades

Paul A. MahonEVP & General Counsel
Planned sale10b5-1 planUnited Therapeutics
Planned sale10b5-1 plan
United Therapeutics
UTHR
$4.1M
8,300 sh
$4.1M
Filed 09/17
Traded 09/17
Paul A. MahonEVP & General Counsel
Planned sale10b5-1 planUnited Therapeutics
Planned sale10b5-1 plan
United Therapeutics
UTHR
$4M
8,300 sh
$4M
Filed 09/03
Traded 09/03
Paul A. MahonEVP & General Counsel
Planned sale10b5-1 planUnited Therapeutics
Planned sale10b5-1 plan
United Therapeutics
UTHR
$4.3M
8,300 sh
$4.3M
Filed 08/20
Traded 08/20
Paul A. MahonEVP & General Counsel
Planned sale10b5-1 planUnited Therapeutics
Planned sale10b5-1 plan
United Therapeutics
UTHR
$4.3M
8,300 sh
$4.3M
Filed 08/06
Traded 08/06
Paul A. MahonEVP & General Counsel
Planned sale10b5-1 planUnited Therapeutics
Planned sale10b5-1 plan
United Therapeutics
UTHR
$4.4M
8,300 sh
$4.4M
Filed 07/16
Traded 07/16